Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders

Jeffrey Conn, P., Christopoulos, Arthur, Lindsley, Craig W.·2009·Nature Reviews Drug Discovery

DOI 10.1038/nrd2760

Cited by (1,000)

Items 101–200 of 1,000

Computational approaches to mapping allosteric pathways
Victoria A. Feher, Jacob D. Durrant, Adam T. Van Wart, Rommie E. Amaro · 2014 · Current Opinion in Structural Biology
Structure and ligand recognition of class C GPCRs
Lei Chun, Wenhua Zhang, Jianfeng Liu · 2012 · Acta Pharmacologica Sinica
Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders
Sean P. Moran, James Maksymetz, Peter Jeffrey Conn · 2019 · Trends in Pharmacological Sciences
Dynamics of the β 2 -Adrenergic G-Protein Coupled Receptor Revealed by Hydrogen−Deuterium Exchange
Xi Zhang, Ellen Y. T. Chien, Michael J. Chalmers, Bruce D. Pascal, Jovylyn Gatchalian, Raymond C. Stevens, Patrick R. Griffin · 2010 · Analytical Chemistry
Allostery at opioid receptors: modulation with small molecule ligands
Kathryn E. Livingston, John R. Traynor · 2017 · British Journal of Pharmacology
Dual Allosteric Inhibition of SHP2 Phosphatase
Michelle Fodor, Edmund V. Price, Ping Wang, Hengyu Lu, Andreea Argintaru, Zhouliang Chen, Meir Glick, Huai-Xiang Hao, Mitsunori Kato, Robert Koenig et al. · 2018 · ACS Chemical Biology
Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction
Kathryn A. Cunningham, Noelle C. Anastasio · 2013 · Neuropharmacology
Probe Dependence in the Allosteric Modulation of a G Protein-Coupled Receptor: Implications for Detection and Validation of Allosteric Ligand Effects
Céline Valant, Christian C. Felder, Patrick Michael Sexton, Arthur Christopoulos · 2011 · Molecular Pharmacology
Detection of secondary binding sites in proteins using fragment screening
R. Frederick Ludlow, Marcel L. Verdonk, Harpreet Kaur Saini, Ian J. Tickle, Harren Jhoti · 2015 · Proceedings of the National Academy of Sciences
NIDA’s medication development priorities in response to the Opioid Crisis: ten most wanted
Rasmussen, Kurt, White, David A., Acri, Jane B. · 2019 · Neuropsychopharmacology
Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling
Corentin Herbert, Ulrich Schieborr, Krishna Saxena, Jarek Juraszek, Frederik De Smet, Chantal Alcouffe, Marc Bianciotto, Giorgio Saladino, David Sibrac, D. Kudlinzki et al. · 2013 · Cancer Cell
Illuminating the activation mechanisms and allosteric properties of metabotropic glutamate receptors
Etienne Doumazane, Pauline Scholler, Ludovic Fabre, Jurriaan M. Zwier, Eric Trinquet, Jean‐Philippe Pin, Philippe Rondard · 2013 · Proceedings of the National Academy of Sciences
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefanía Moreno, Milena R. Cavic, Ana Krivokuća, Vicent Casadó, Enric I. Canela · 2019 · Frontiers in Pharmacology
Functional Impact of Allosteric Agonist Activity of Selective Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 in Regulating Central Nervous System Function
Meredith J. Noetzel, Jerri M. Rook, Paige N. Vinson, Hyekyung P. Cho, Emily Days, Ya Zhou, Alice L. Rodriguez, Hilde Lavreysen, Shaun R. Stauffer, Colleen Marie Niswender et al. · 2011 · Molecular Pharmacology
Tellurium-Containing Polymer Micelles: Competitive-Ligand-Regulated Coordination Responsive Systems
Wei Cao, Yuwei Gu, Myriam Meineck, Tianyu Li, Huaping Xu · 2014 · Journal of the American Chemical Society
AI-Based Protein Structure Prediction in Drug Discovery: Impacts and Challenges
Schauperl, Michael, Denny, Rajiah Aldrin · 2022 · Journal of Chemical Information and Modeling
ASD v3.0: unraveling allosteric regulation with structural mechanisms and biological networks
Shen, Qiancheng, Wang, Guanqiao, Li, Shuai, Liu, Xinyi, Lu, Shaoyong, Chen, Zhongjie, Song, Kun, Yan, Junhao, Geng, Lv, Huang, Zhimin et al. · 2016 · Nucleic Acids Research
Differences in Allosteric Communication Pipelines in the Inactive and Active States of a GPCR
S. Bhattacharya, Nagarajan Vaidehi · 2014 · Biophysical Journal
Thermostabilisation of an Agonist-Bound Conformation of the Human Adenosine A2A Receptor
Guillaume Lebon, Kirstie A. Bennett, Ali Jazayeri, Christopher G. Tate · 2011 · Journal of Molecular Biology
Allosteric modulation of the M1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer's disease
Bruce J. Melancon, James Christopher Tarr, Joseph D. Panarese, Michael R. Wood, Craig W. Lindsley · 2013 · Drug Discovery Today
A Guide to Targeting the Endocannabinoid System in Drug Design
Adam Stasiulewicz, Katarzyna Znajdek, Monika K. Grudzień, Tomasz Pawiński, Joanna Ida Sulkowska · 2020 · International Journal of Molecular Sciences
Allosteric modulation of metabotropic glutamate receptors: Structural insights and therapeutic potential
Karen J. Gregory, Elizabeth N. Dong, Jens Meiler, Peter Jeffrey Conn · 2010 · Neuropharmacology
Identification and Pharmacological Characterization of Multiple Allosteric Binding Sites on the Free Fatty Acid 1 Receptor
Daniel Chi-Hong Lin, Qi Guo, Jian Luo, Jane Zhang, Kathy Nguyen, Michael J. Chen, Thanh Tran, Paul J. Dransfield, Sean P. Brown, Jonathan B. Houze et al. · 2012 · Molecular Pharmacology
Revealing Atomic-Level Mechanisms of Protein Allostery with Molecular Dynamics Simulations
Hertig, Samuel, Latorraca, Naomi R., Dror, Ron O. · 2016 · PLOS Computational Biology
Drug discovery in the next decade: innovation needed ASAP
Youssef L. Bennani · 2011 · Drug Discovery Today
Allosteric drugs and mutations: chances, challenges, and necessity
Enrico Guarnera, Igor N. Berezovsky · 2020 · Current Opinion in Structural Biology
Rational design of dualsteric GPCR ligands: quests and promise
Klaus Mohr, Christian Tränkle, Evi Kostenis, Elisabetta Barocelli, Marco De Amici, Ulrike Holzgrabe · 2010 · British Journal of Pharmacology
Overview of Muscarinic Receptor Subtypes
Richard M. Eglen · 2011 · Handbook of experimental pharmacology
Pharmacologic Evidence for a Putative Conserved Allosteric Site on Opioid Receptors
Kathryn E. Livingston, M. Alexander Stanczyk, Neil T. Burford, Andrew J. Alt, Meritxell Canals, John R. Traynor · 2017 · Molecular Pharmacology
Positive allosteric modulators of the μ‐opioid receptor: a novel approach for future pain medications
Neil T. Burford, John R. Traynor, Andrew J. Alt · 2014 · British Journal of Pharmacology
The Design of Covalent Allosteric Drugs
Nussinov, Ruth, Tsai, Chung-Jung · 2015 · Annual Review of Pharmacology and Toxicology
Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development
Alice Egerton, Anthony A. Grace, James M. Stone, Matthijs Geert Bossong, Michael S. Sand, Philip K. McGuire · 2020 · Schizophrenia Research
Mapping the Druggable Allosteric Space of G‐Protein Coupled Receptors: a Fragment‐Based Molecular Dynamics Approach
Anthony Ivetac, James Andrew McCammon · 2010 · Chemical Biology & Drug Design
A Monod-Wyman-Changeux Mechanism Can Explain G Protein-coupled Receptor (GPCR) Allosteric Modulation
Meritxell Canals, J. Robert Lane, Adriel Wen, Peter J. Scammells, Patrick Michael Sexton, Arthur Christopoulos · 2011 · Journal of Biological Chemistry
Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects
Zahid Ali, Bart E. Laurijssens, Thor Ostenfeld, Simon M. McHugh, Anastasia Stylianou, Paul Scott‐Stevens, Louise K. Hosking, Odile Dewit, Jill C. Richardson, Chao Chen · 2012 · British Journal of Clinical Pharmacology
GABAB Receptors in Reward Processes
Styliani Vlachou, Athina Markou · 2010 · Advances in pharmacology
GPCR crystal structures: Medicinal chemistry in the pocket
Jeremy Shonberg, Ralf Christian Kling, Peter Gmeiner, Stefan Löber · 2014 · Bioorganic & Medicinal Chemistry
Physicochemical graph neural network for learning protein–ligand interaction fingerprints from sequence data
2024
Ligand-Based Peptide Design and Combinatorial Peptide Libraries to Target G Protein-Coupled Receptors
Christian W. Gruber, Markus Muttenthaler, Michael Freissmuth · 2010 · Current Pharmaceutical Design
Dopamine Receptor Signaling and Current and Future Antipsychotic Drugs
Kevin N. Boyd, Richard B. Mailman · 2012 · Handbook of experimental pharmacology
Discovery of the First Highly M5-Preferring Muscarinic Acetylcholine Receptor Ligand, an M5 Positive Allosteric Modulator Derived from a Series of 5-Trifluoromethoxy N -Benzyl Isatins
Thomas M. Bridges, Joy E. Marlo, Colleen Marie Niswender, Carrie K. Jones, Satyawan B Jadhav, Patrick R. Gentry, Hyekyung C. Plumley, C. David Weaver, Peter Jeffrey Conn, Craig W. Lindsley · 2009 · Journal of Medicinal Chemistry
Modeling general proteostasis: proteome balance in health and disease
Daniela Roth, William E. Balch · 2010 · Current Opinion in Cell Biology
Future applications of FGF/FGFR inhibitors in cancer
Gaia Cristina Ghedini, Roberto Ronca, Marco Presta, Arianna Giacomini · 2018 · Expert Review of Anticancer Therapy
Detecting Allosteric Networks Using Molecular Dynamics Simulation
Samuel Bowerman, Jeff Wereszczynski · 2016 · Methods in enzymology on CD-ROM/Methods in enzymology
Ghrelin: From a gut hormone to a potential therapeutic target for alcohol use disorder
Mehdi Farokhnia, Monica L. Faulkner, Daria Piacentino, Mary R. Lee, Lorenzo Leggio · 2019 · Physiology & Behavior
Artificial membrane-like environments for in vitro studies of purified G-protein coupled receptors
Eugene Serebryany, Gefei Alex Zhu, Elsa C. Y. Yan · 2011 · Biochimica et Biophysica Acta (BBA) - Biomembranes
Unique Signaling Profiles of Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Determine Differences in In Vivo Activity
Jerri M. Rook, Meredith J. Noetzel, Wendy A. Pouliot, Thomas M. Bridges, Paige N. Vinson, Hyekyung P. Cho, Ya Zhou, Rocco D. Gogliotti, Jason T. Manka, Karen J. Gregory et al. · 2012 · Biological Psychiatry
ASD v2.0: updated content and novel features focusing on allosteric regulation
Zhimin Huang, Linkai Mou, Qiancheng Shen, Shaoyong Lu, Chuangang Li, Xinyi Liu, Guanqiao Wang, Shuai Li, Lv Geng, Yaqin Liu et al. · 2013 · Nucleic Acids Research
Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development
Thuy Nguyen, Brian F. Thomas, Yanan Zhang · 2019 · Current Topics in Medicinal Chemistry
From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer’s disease
Alastair Brown, Sophie J. Bradley, Fiona H. Marshall, Giles A. Brown, Kirstie A. Bennett, Jason D. Brown, Julie E. Cansfield, David M. Cross, Chris de Graaf, Brian D. Hudson et al. · 2021 · Cell
Discovery and Characterization of Novel Subtype-Selective Allosteric Agonists for the Investigation of M1 Receptor Function in the Central Nervous System
Evan P. Lebois, Thomas M. Bridges, L. Michelle Lewis, Eric S. Dawson, Alexander S. Kane, Zixiu Xiang, Satyawan B Jadhav, Huiyong Yin, J. Phillip Kennedy, Jens Meiler et al. · 2009 · ACS Chemical Neuroscience
Synergy between l-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: Implications for Parkinson's disease treatment and dyskinesia
Khaled-Ezaheir Bennouar, Michelle A. Uberti, Christophe Melon, Maria D. Bacolod, Hermogenes N. Jimenez, Manuel Cajina, Lydia Kerkerian‐Le Goff, Darı́o Doller, Paolo Gubellini · 2012 · Neuropharmacology
From synapse to nucleus: Novel targets for treating depression
Covington, Herbert E., Vialou, Vincent, Nestler, Eric J. · 2010 · Neuropharmacology
From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists
Guy A. Higgins, Edward M. Sellers, Paul J. Fletcher · 2013 · Trends in Pharmacological Sciences
Allosteric Modulators of G Protein-Coupled Receptors: Future Therapeutics for Complex Physiological Disorders
Liyun Wang, Bronwen Martin, Randall Brenneman, Louis M. Luttrell, Stuart R. Maudsley · 2009 · Journal of Pharmacology and Experimental Therapeutics
Allosteric ligands for G protein-coupled receptors: A novel strategy with attractive therapeutic opportunities
Marco De Amici, Clelia Dallanoce, Ulrike Holzgrabe, Christian Tränkle, Klaus Mohr · 2009 · Medicinal Research Reviews
A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential
Cyril Goudet, Bruno Vilar, Tiphanie Courtiol, Thierry Deltheil, Thomas Bessiron, Isabelle Brabet, Nadia Oueslati, Delphine Rigault, Hugues‐Olivier Bertrand, Heather McLean et al. · 2012 · The FASEB Journal
Targeting glutamate synapses in schizophrenia
Julie R. Field, Adam G. Walker, Peter Jeffrey Conn · 2011 · Trends in Molecular Medicine
In Silico and In Vitro Analysis of Bacoside A Aglycones and Its Derivatives as the Constituents Responsible for the Cognitive Effects of Bacopa monnieri
Seetha Ramasamy, Sek Peng Chin, Sri Devi Sukumaran, Michael J. C. Buckle, Lik Voon Kiew, Lip Yong Chung · 2015 · PLoS ONE
A Novel Biased Allosteric Compound Inhibitor of Parturition Selectively Impedes the Prostaglandin F2α-mediated Rho/ROCK Signaling Pathway
Eugénie Goupil, Danaë Tassy, Carine B. Bourguet, Christiane Quiniou, Veronica Wisehart, Darlaine Pétrin, Christian Le Gouill, Dominic Devost, Hans H. Zingg, Michel Bouvier et al. · 2010 · Journal of Biological Chemistry
Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor
Thuy Nguyen, Jun‐Xu Li, Brian F. Thomas, Jenny L. Wiley, Terry Kenakin, Yanan Zhang · 2016 · Medicinal Research Reviews
G-protein coupled receptors: advances in simulation and drug discovery
Miao, Yinglong, McCammon, J Andrew · 2016 · Current Opinion in Structural Biology
Allosteric targeting of receptor tyrosine kinases
Frederik De Smet, Arthur Christopoulos, Peter Carmeliet · 2014 · Nature Biotechnology
Fine-Tuning Multiprotein Complexes Using Small Molecules
Andrea D. Thompson, Amanda E. Dugan, Jason E. Gestwicki, Anna K. Mapp · 2012 · ACS Chemical Biology
AlloFinder: a strategy for allosteric modulator discovery and allosterome analyses
Min Huang, Kun Song, Xinyi Liu, Shaoyong Lu, Qiancheng Shen, Renxiao Wang, Jingze Gao, Yuanyuan Hong, Qian Li, Duan Ni et al. · 2018 · Nucleic Acids Research
Diverse modes of NMDA receptor positive allosteric modulation: Mechanisms and consequences
David H. Hackos, Jesse E. Hanson · 2016 · Neuropharmacology
Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia
Jerri M. Rook, Derrick Choi, Daniel J. Foster, Peter Jeffrey Conn · 2014 · Neuropsychiatric Disease and Treatment
GABAB receptors as a therapeutic strategy in substance use disorders: Focus on positive allosteric modulators
Małgorzata Filip, Małgorzata Frankowska, Anna Sadakierska−Chudy, Agata Suder, Łukasz Szumiec, Paweł Mierzejewski, Przemysław Bieńkowski, Edmund Przegaliński, John F. Cryan · 2014 · Neuropharmacology
Recent advances in dopaminergic strategies for the treatment of Parkinson’s disease
Qi Mao, Wangzhi Qin, Ao Zhang, Na Ye · 2020 · Acta Pharmacologica Sinica
Reversing allosteric communication: From detecting allosteric sites to inducing and tuning targeted allosteric response
Wei-Ven Tee, Enrico Guarnera, Igor N. Berezovsky · 2018 · PLoS Computational Biology
Cognitive Enhancers (Nootropics). Part 1: Drugs Interacting with Receptors
Wolfgang Froestl, Andreas Muhs, Andrea Pfeifer · 2012 · Journal of Alzheimer s Disease
Orthosteric/Allosteric Bitopic Ligands: Going Hybrid at GPCRs
Céline Valant, Patrick Michael Sexton, Arthur Christopoulos · 2009 · Molecular Interventions
The complexity of their activation mechanism opens new possibilities for the modulation of mGlu and GABAB class C G protein-coupled receptors
Philippe Rondard, Cyril Goudet, Julie Kniazeff, Jean‐Philippe Pin, Laurent Prézeau · 2010 · Neuropharmacology
Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development
Jennifer Ann Kricker, Clive Peter Page, Fridrik Runar Gardarsson, Ólafur Baldursson, Þórarinn Guðjónsson, Michael John Parnham · 2021 · Pharmacological Reviews
Metabotropic Glutamate Receptors as Therapeutic Targets for Schizophrenia
P. Vinson, P. Conn · 2011 · Neuropharmacology
Allosteric Modulators for the Treatment of Schizophrenia: Targeting Glutamatergic Networks
Frank S. Menniti, Craig W. Lindsley, Peter Jeffrey Conn, Jayvardhan Pandit, Panayiotis Zagouras, Robert A. Volkmann · 2013 · Current Topics in Medicinal Chemistry
Fragment Screening of GPCRs Using Biophysical Methods: Identification of Ligands of the Adenosine A2A Receptor with Novel Biological Activity
Dan Chen, James C. Errey, Laura H. Heitman, Fiona H. Marshall, Adriaan P. IJzerman, Gregg Siegal · 2012 · ACS Chemical Biology
Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor
Yinglong Miao, Dahlia A. Goldfeld, Ee Von Moo, Patrick Michael Sexton, Arthur Christopoulos, James Andrew McCammon, Céline Valant · 2016 · Proceedings of the National Academy of Sciences
Chemical, Target, and Bioactive Properties of Allosteric Modulation
Gerard J. P. van Westen, Anna Gaulton, John P. Overington · 2014 · PLoS Computational Biology
Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor
Jianxiong Jiang, Thota Ganesh, Yuhong Du, Pahk Thepchatri, Asheebo Rojas, Iestyn Lewis, Serdar Kurtkaya, Lian Li, Min Qui, Geidy E. Serrano et al. · 2010 · Proceedings of the National Academy of Sciences
Recent updates on GPCR biased agonism
André Sampaio Pupo, Diego Ângelo Duarte, Vanessa Lima, Larissa B. Teixeira, Lucas T. Parreiras‐e‐Silva, Cláudio M. Costa-Neto · 2016 · Pharmacological Research
Rapid and High-Sensitivity Cell-Based Assays of Protein−Protein Interactions Using Split Click Beetle Luciferase Complementation: An Approach to the Study of G-Protein-Coupled Receptors
Naomi Misawa, A. K. M. Kafi, Mitsuru Hattori, Kenji Miura, Kenji Masuda, Takeaki Ozawa · 2010 · Analytical Chemistry
Structural biology of GABAB receptor
Aurel Frangaj, Qing Fan · 2017 · Neuropharmacology
LM-GVP: an extensible sequence and structure informed deep learning framework for protein property prediction
Zichen Wang, Steven A. Combs, Ryan M. Brand, Miguel Romero Calvo, Panpan Xu, George Price, Nataliya Golovach, Emmanuel Oluwatobi Salawu, Colby Wise, Sri Priya Ponnapalli et al. · 2022 · Scientific Reports
Strategies for the identification of allosteric modulators of G-protein-coupled receptors
Neil T. Burford, John Watson, Robert L. Bertekap, Andrew J. Alt · 2010 · Biochemical Pharmacology
Quantitative imaging of protein targets in the human brain with PET
Roger N. Gunn, Mark Slifstein, Graham E. Searle, Julie C. Price · 2015 · Physics in Medicine and Biology
50th anniversary of the word “allosteric”
Jean‐Pierre Changeux · 2011 · Protein Science
OptoGluNAM4.1, a Photoswitchable Allosteric Antagonist for Real-Time Control of mGlu 4 Receptor Activity
Xavier Rovira, Ana Trapero, Silvia Pittolo, Charleine Zussy, Adèle Faucherre, Chris Jopling, Jesús Giraldo, Jean‐Philippe Pin, Pau Gorostiza, Cyril Goudet et al. · 2016 · Cell chemical biology
Targeting human Mas-related G protein-coupled receptor X1 to inhibit persistent pain
Zhe Li, Pang-Yen Tseng, Vinod Tiwari, Qian Xu, Shao-Qiu He, Yan Wang, Zheng Hong Qin, Liang Han, Zhiping Wu, Anna Louise Blobaum et al. · 2017 · Proceedings of the National Academy of Sciences
G-Protein Coupled Receptors and Tau-different Roles in Alzheimer’s Disease
Hariharakrishnan Chidambaram, Subashchandrabose Chinnathambi · 2020 · Neuroscience
A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid
Hebaallah Mamdouh Hashiesh, Charu Sharma, Sameer N. Goyal, Bassem Shaban Sadek, Niraj Kumar Jha, Juma Al Kaabi, Shreesh Kumar Ojha · 2021 · Biomedicine & Pharmacotherapy
Therapeutic Potential of 5-HT 2C Receptor Agonists for Addictive Disorders
Guy A. Higgins, Paul J. Fletcher · 2015 · ACS Chemical Neuroscience
GABBR2 mutations determine phenotype in rett syndrome and epileptic encephalopathy
Yongjin Yoo, Jane Jung, Yoo‐Na Lee, Youngha Lee, Hyosuk Cho, Eunjung Na, JeaYeok Hong, Eunjin Kim, Jin Sook Lee, Je‐Sang Lee et al. · 2017 · Annals of Neurology
Molecular Alliance—From Orthosteric and Allosteric Ligands to Dualsteric/Bitopic Agonists at G Protein Coupled Receptors
Klaus Mohr, Jens Schmitz, Ramona Schrage, Christian Tränkle, Ulrike Holzgrabe · 2012 · Angewandte Chemie International Edition
Synthesis and Evaluation of a Series of Heterobiarylamides That Are Centrally Penetrant Metabotropic Glutamate Receptor 4 (mGluR4) Positive Allosteric Modulators (PAMs)
Darren W. Engers, Colleen Marie Niswender, C. David Weaver, Satyawan B Jadhav, Usha N. Menon, Rocio Zamorano, Peter Jeffrey Conn, Craig W. Lindsley, Corey R. Hopkins · 2009 · Journal of Medicinal Chemistry
Context-Dependent Pharmacology Exhibited by Negative Allosteric Modulators of Metabotropic Glutamate Receptor 7
Colleen Marie Niswender, Kari A. Johnson, Nicole Miller, Jennifer E. Ayala, Qingwei Luo, Richard Dafydd Williams, Samir Saleh, Darren Orton, C. David Weaver, Peter Jeffrey Conn · 2009 · Molecular Pharmacology
M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss
Sophie J. Bradley, Julie-Myrtille Bourgognon, Helen Sanger, Nicholas Verity, Adrian J. Mogg, David White, Adrian J. Butcher, Julie A. Moreno, Colin Molloy, Timothy Macedo-Hatch et al. · 2016 · Journal of Clinical Investigation
Novel mGluR5 Positive Allosteric Modulator Improves Functional Recovery, Attenuates Neurodegeneration, and Alters Microglial Polarization after Experimental Traumatic Brain Injury
David J. Loane, Bogdan A. Stoica, Flaubert Tchantchou, Alok Kumar, James P. Barrett, Titilola Akintola, Fengtian Xue, Peter Jeffrey Conn, Alan I. Faden · 2014 · Neurotherapeutics
Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction
Michael Foster Olive · 2010 · European Journal of Pharmacology
Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder
Sunil Goodwani, Hannah C. Saternos, Fawaz F. Alasmari, Youssef Sari · 2017 · Neuroscience & Biobehavioral Reviews